Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.205
-0.045 (-2.00%)
Aug 13, 2025, 4:00 PM - Market closed
Purple Biotech Employees
Purple Biotech had 9 employees as of December 31, 2024. The number of employees decreased by 11 or -55.00% compared to the previous year.
Employees
9
Change (1Y)
-11
Growth (1Y)
-55.00%
Revenue / Employee
n/a
Profits / Employee
-$290,111
Market Cap
6.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PPBT News
- 7 days ago - Purple Biotech Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025 - GlobeNewsWire
- 7 weeks ago - Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress - GlobeNewsWire
- 3 months ago - Purple Biotech Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Purple Biotech Appoints Shai Lankry as Chief Financial Officer - GlobeNewsWire
- 3 months ago - Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers - GlobeNewsWire
- 5 months ago - Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial - GlobeNewsWire